Cagrilintide Phase 2 monotherapy (Lau et al., Lancet 2021) reported about 10.8% weight loss at 26 weeks at 4.5 mg
Im on top of the world! patient of Skin MD and Beyond Lisa
Intramuscular injection delivers absolute bioavailability between 14 to 20% compared to intravenous dosing
For those who are seasoned NAD+ users, or that are administering higher doses (more than 50 units weekly), we recommend ordering a 5mL vial to support a full monthly supply
I was encouraged by the committees recommendation because it creates an opportunity to move patients away from unverified research use only (RUO), otherwise known as grey market products, and toward a more accountable medical pathway, LaValle said
Most of the weight-loss medications right nowWegovy, Zepbound, and otherswork by targeting the GLP-1 pathway